- cafead   Oct 13, 2023 at 10:52: AM
via Swiss biotech Santhera is on the brink of its first regulatory approval for Duchenne muscular dystrophy treatment vamorolone, after getting a positive opinion on the drug from the EMA’s human medicines committee.
article source
article source